Omeprazole
Code | Size | Price |
---|
TAR-T0757-50mg | 50mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0757-100mg | 100mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0757-1mL | 1 mL * 10 mM (in DMSO) | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0757-200mg | 200mg | £121.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0757-500mg | 500mg | £148.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Omeprazole is a proton pump inhibitor (PPI), Omeprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).
CAS:
73590-58-6
Formula:
C17H19N3O3S
Molecular Weight:
345.42
Pathway:
Microbiology/Virology; Metabolism; Membrane transporter/Ion channel; Autophagy
Purity:
0.9959
SMILES:
COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C
Target:
Proton pump; Phospholipase; Antibacterial; Autophagy
References
1. Dzeletovic N, et al. J Biol Chem, 1997, 272(19), 12705-12713.
2. Scaringi L, et al. Scand J Immunol, 1996, 44(3), 204-214.
3. Hyun JJ, et al. Int J Mol Med, 2010, 26(6), 877-883.
4. Karam SM, et al. Am J Physiol, 1994, 266(4 Pt 1), G745-758.
5. Kang D, Pang X, Lian W, et al. Discovery of VEGFR2 inhibitors by integrating na?ve Bayesian classification, molecular docking and drug screening approaches[J]. RSC Advances. 2018 Jan 8(10): 5286-5297.